Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perianal infiltration with ropivacaine during RAFAELO procedure for hemorrhoidal disease
2024-514117-35-00Phase 4Completed
- Sponsor
- CHD Vendée
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in hemorrhoid (2 arms), sponsored by CHD Vendée. Primary endpoint: Visual analogue scale (VAS) pain score at 6 hours post-operation. Started May 2024; status: completed.
02
Drugs
ropivacaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on 2024-514117-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514117-35-00.